These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34079770)

  • 21. Revisiting Repurposing.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing Drugs for Skin Cancer.
    Khachigian LM
    Curr Med Chem; 2020; 27(42):7214-7221. PubMed ID: 31858902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug repurposing: progress, challenges and recommendations.
    Pushpakom S; Iorio F; Eyers PA; Escott KJ; Hopper S; Wells A; Doig A; Guilliams T; Latimer J; McNamee C; Norris A; Sanseau P; Cavalla D; Pirmohamed M
    Nat Rev Drug Discov; 2019 Jan; 18(1):41-58. PubMed ID: 30310233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
    Lago SG; Bahn S
    ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Old drugs, new uses: Drug repurposing in hematological malignancies.
    Kale VP; Habib H; Chitren R; Patel M; Pramanik KC; Jonnalagadda SC; Challagundla K; Pandey MK
    Semin Cancer Biol; 2021 Jan; 68():242-248. PubMed ID: 32151704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposed drug candidates for antituberculosis therapy.
    An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
    Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
    Mittal N; Mittal R
    Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing of gallium-based drugs for antibacterial therapy.
    Bonchi C; Imperi F; Minandri F; Visca P; Frangipani E
    Biofactors; 2014; 40(3):303-12. PubMed ID: 24532037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Drug Repurposing for Parkinson's Disease.
    Chen X; Gumina G; Virga KG
    Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
    Gelosa P; Castiglioni L; Camera M; Sironi L
    Biochem Pharmacol; 2020 Jul; 177():113895. PubMed ID: 32145263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
    Brown D
    Nat Rev Drug Discov; 2015 Dec; 14(12):821-32. PubMed ID: 26493767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving therapy of severe infections through drug repurposing of synergistic combinations.
    Cheng YS; Williamson PR; Zheng W
    Curr Opin Pharmacol; 2019 Oct; 48():92-98. PubMed ID: 31454708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational drug repurposing to predict approved and novel drug-disease associations.
    Khalid Z; Sezerman OU
    J Mol Graph Model; 2018 Oct; 85():91-96. PubMed ID: 30130693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new computational drug repurposing method using established disease-drug pair knowledge.
    Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
    Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
    Wright GD
    Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.
    Adeniji AA; Knoll KE; Loots DT
    Appl Microbiol Biotechnol; 2020 Jul; 104(13):5633-5662. PubMed ID: 32372202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
    Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
    Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of computational drug repurposing.
    Park K
    Transl Clin Pharmacol; 2019 Jun; 27(2):59-63. PubMed ID: 32055582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing Novel Anticancer Drugs for Targeted Populations: An Update.
    Tafesse TB; Bule MH; Khan F; Abdollahi M; Amini M
    Curr Pharm Des; 2021; 27(2):250-262. PubMed ID: 33234093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug repurposing using real-world data.
    Tan GSQ; Sloan EK; Lambert P; Kirkpatrick CMJ; Ilomäki J
    Drug Discov Today; 2023 Jan; 28(1):103422. PubMed ID: 36341896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.